The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Georges Vauquelin

Free University Brussels (VUB)

Molecular and Biochemical Pharmacology Department

Pleinlaan 2

B-1050 Brussels

[email]@vub.ac.be

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Free University Brussels (VUB), Molecular and Biochemical Pharmacology Department, Pleinlaan 2, B-1050 Brussels. 1999 - 2012

References

  1. Radioligand dissociation measurements: potential interference of rebinding and allosteric mechanisms and physiological relevance of the biological model systems. Vauquelin, G., Van Liefde, I. Expert. Opin. Drug. Discov (2012) [Pubmed]
  2. Clozapine, atypical antipsychotics, and the benefits of fast-off D(2) dopamine receptor antagonism. Vauquelin, G., Bostoen, S., Vanderheyden, P., Seeman, P. Naunyn Schmiedebergs Arch. Pharmacol. (2012) [Pubmed]
  3. Ligands, their receptors and ... plasma membranes. Vauquelin, G., Packeu, A. Mol. Cell. Endocrinol. (2009) [Pubmed]
  4. Kinetic versus allosteric mechanisms to explain insurmountable antagonism and delayed ligand dissociation. Vauquelin, G., Szczuka, A. Neurochem. Int. (2007) [Pubmed]
  5. Long-lasting angiotensin type 1 receptor binding and protection by candesartan: comparison with other biphenyl-tetrazole sartans. Vauquelin, G., Fierens, F., Van Liefde, I. J. Hypertens. Suppl (2006) [Pubmed]
  6. Slow antagonist dissociation and long-lasting in vivo receptor protection. Vauquelin, G., Van Liefde, I. Trends Pharmacol. Sci. (2006) [Pubmed]
  7. Models and methods for studying insurmountable antagonism. Vauquelin, G., Van Liefde, I., Vanderheyden, P. Trends Pharmacol. Sci. (2002) [Pubmed]
  8. New insights in insurmountable antagonism. Vauquelin, G., Van Liefde, I., Birzbier, B.B., Vanderheyden, P.M. Fundam. Clin. Pharmacol (2002) [Pubmed]
  9. A two-state receptor model for the interaction between angiotensin II type 1 receptors and non-peptide antagonists. Vauquelin, G., Morsing, P., Fierens, F.L., De Backer, J.P., Vanderheyden, P.M. Biochem. Pharmacol. (2001) [Pubmed]
  10. The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cells. Vauquelin, G., Fierens, F.L., De Backer, J.P., Vanderheyden, P.M. J. Am. Soc. Nephrol. (1999) [Pubmed]
 
WikiGenes - Universities